Zobrazeno 1 - 10
of 1 761
pro vyhledávání: '"recombinant factor VIII"'
Autor:
Dong Wang, Wenzhe Chen, Jiali Chen, Du He, Yanli Pan, Pinger Wang, Qinghe Zeng, Mancang Gu, Peijian Tong, Di Chen, Hongting Jin
Publikováno v:
Bioactive Materials, Vol 40, Iss , Pp 47-63 (2024)
In individuals afflicted with hemophilia, characterized by a deficiency of coagulation factor VIII (FVIII), the occurrence of spontaneous recurrent intra-articular hemorrhage precipitates the emergence of hemophilic arthropathy (HA). Although clottin
Externí odkaz:
https://doaj.org/article/0044da476f984a10934c93726ec4836b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss 1 (2024)
Although the use of prophylaxis regimens with prolonged half-life factors is now widespread in the world of hemophilia A, there is a lack of real-life evidence on the impact of these products on joint health, adherence, and quality of life of patient
Externí odkaz:
https://doaj.org/article/642f684552ae4a348e003b6ca66d2792
Autor:
Tulika Seth, Kapil Garg, Prakas Kumar Mandal, Anupam Datta, Shailendra Verma, Suresh Hanagavadi, Usha Rani Thota
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTAim Hemophilia A (HA) is an inherited bleeding disorder caused by a deficiency of clotting factor VIII in the blood. In resource-limited settings like India, affordability is a significant challenge in managing patients with severe HA. This s
Externí odkaz:
https://doaj.org/article/8aeef719309b48ed9808db53bfba584f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Blood Medicine, Vol Volume 13, Pp 505-516 (2022)
Enrico Ferri Grazzi,1 Shawn X Sun,2 Tom Burke,1,3 Jamie O’Hara1,3 1Health Economics and Outcomes Research, HCD Economics Ltd, Daresbury, Warrington, UK; 2Global Evidence and Outcomes, Takeda Development Center Americas, Inc, Cambridge, MA, USA; 3De
Externí odkaz:
https://doaj.org/article/b8d38e37f2ea4e6aa0dcec465bf22957
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 71, Iss 1, Pp 62-66 (2021)
Objective: To evaluate the efficacy of recombinant factor VIII FC fusion protein in haemophilia A patient receiving on demand treatment only. Study Design: Comparative cross sectional study. Place and Duration of Study: Department of Hematology
Externí odkaz:
https://doaj.org/article/c23e28d5cefa4fad8017bd77710391d3
Publikováno v:
Journal of Blood Medicine, Vol Volume 12, Pp 883-896 (2021)
Barbara A Konkle,1 Doris V Quon,2 Leslie Raffini,3 Michael Recht,4 Vlad C Radulescu,5 Shannon L Carpenter,6 Amy L Dunn,7 Mei Lu,8 Maureen Watt9 1Department of Medicine, The University of Washington and Bloodworks Northwest, Seattle, WA, USA; 2Orthopa
Externí odkaz:
https://doaj.org/article/9bd5545503944bd5ac93814c5f9ab3a7
Publikováno v:
Asian Journal of Transfusion Science, Vol 15, Iss 2, Pp 237-240 (2021)
Hemophilia A is an X-linked recessive bleeding disorder occurs due to deficiency of factor VIII (FVIII). The disease manifests exclusively in males though it rarely occurs in females due to complex pathophysiological mechanisms. We present a rare cas
Externí odkaz:
https://doaj.org/article/7877e0861b2d42109bc98d5d9390a454
Autor:
Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 16, Pp 567-578 (2020)
Runhui Wu,1 Jing Sun,2 Weiqun Xu,3 Qun Hu,4 Wenqian Li,5 Jianwen Xiao,6 Feng’e Yang,7 Xiaojing Zeng,8 Yun Zeng,9 Jianfeng Zhou,4 Irina Matytsina,10 Sali Zhang,11 Michael Pluta,12 Renchi Yang13 1Hematology Oncology Center, Beijing Children’s Hospi
Externí odkaz:
https://doaj.org/article/8f16c00516164c3a87a7fd931c2b8412